Aardvark Therapeutics (AARD) Share-based Compensation (2024 - 2026)
Aardvark Therapeutics (AARD) recorded Share-based Compensation of $1.95 million in Q2 2026, up 207.6% from $634,000 a year earlier but down 2.7% from the prior quarter.
Powered by 
Analysis
Aardvark Therapeutics (AARD) Share-based Compensation (2024 - 2026) Analysis & Trends
On a TTM basis, Aardvark Therapeutics' Share-based Compensation came in at $7.04 million as of Jun 30, 2026, up 493.7% year-over-year; for FY2025, it was $3.95 million, up 799.3% from FY2024.
- Across earlier years, Share-based Compensation came in at $439,000 in FY2024.
- Quarterly Share-based Compensation has ranged from $54,000 in Q2 2024 to $2 million in Q1 2026 over the past five years.
- On a year-over-year basis, Share-based Compensation has increased for four consecutive quarters, with growth averaging 592.8% over the last five quarters.
- Per Business Quant, the preceding three quarters came in at $2 million (Q1 2026), $1.58 million (Q4 2025) and $1.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.85 Bn | 1,106.43 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 618.85 Bn | 537.37 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.03 Bn | 476.14 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 368.52 Bn | 322.90 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.19 Bn | 262.18 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.33 Bn | 235.02 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.14 Bn | 192.53 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.35 Bn | 165.54 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 169.80 Bn | 116.45 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Aardvark Therapeutics | 96.78 Mn | 22.88 Mn | - | 1.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.95 Mn |
| Mar 31, 2026 | 2.00 Mn |
| Dec 31, 2025 | 1.58 Mn |
| Sep 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 634,000.00 |
| Mar 31, 2025 | 233,000.00 |
| Dec 31, 2024 | 173,000.00 |
| Sep 30, 2024 | 144,000.00 |
| Jun 30, 2024 | 53,000.00 |
| Mar 31, 2024 | 67,000.00 |
API Access
Aardvark Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AARD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "AARD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AARD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();